Ng Email Address

Vice President, Head of Medical Affairs

Pharmacyclics, Inc. (NASDAQ: PCYC) is a biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The company's mission is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medical needs. It will do so by identifying and controlling promising product candidates based on scientific development and administrative expertise, developing its products in a rapid, cost-efficient manner and, pursuing commercialization and/or development partners when and where appropriate. Pharmacyclics markets IMBRUVICA and has three product candidates in clinical development and several preclinical molecules in lead optimization. The company is committed to high standards of ethics, scientific rigor and operational efficiency as it moves each of these programs to commercialization. Pharmacyclics is headquartered in Sunnyvale, CA.

Results-driven leader with diversified knowledge and experience across both the global biopharmaceutical and molecular diagnostic industries. Proven track record leading teams, developing actionable medical strategies, creating impactful scientific communications, successfully executing on asset-specific launch readiness plans, driving joint ventures, and leveraging collaborative scientific and clinical research relationships with Key Opinion Leaders. Passionate about following healthcare market trends and evaluating their impact on the future of care delivery. Specialties: Biopharmaceutical and Molecular Diagnostics Industries, Medical Affairs, Scientific Communications, Clinical Trial Management, Joint Ventures, Scientific/Medical Strategy Development, Scientific Assessment/Licensing, Product/Disease State Education, Competitive Assessment, KOL Relationship Management, Launch Planning